Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine

Bioorganic & Medicinal Chemistry Letters
2012.0

Abstract

Phosphoethanolamine N-methyltransferase (PMT) is essential for phospholipid biogenesis in the malarial parasite Plasmodium falciparum. PfPMT catalyzes the triple methylation of phosphoethanolamine to produce phosphocholine, which is then used for phosphatidylcholine synthesis. Here we describe the 2.0Å resolution X-ray crystal structure of PfPMT in complex with amodiaquine. To better characterize inhibition of PfPMT by amodiaquine, we determined the IC(50) values of a series of aminoquinolines using a direct radiochemical assay. Both structural and functional analyses provide a possible approach for the development of new small molecule inhibitors of PfPMT.

Knowledge Graph

Similar Paper

Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine
Bioorganic & Medicinal Chemistry Letters 2012.0
Design, synthesis and antimalarial activity of novel, quinoline-Based, zinc metallo-aminopeptidase inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Antimalarial Activity of Molecules Interfering with Plasmodium falciparum Phospholipid Metabolism. Structure−Activity Relationship Analysis
Journal of Medicinal Chemistry 1997.0
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure–activity relationship and mode of action studies
European Journal of Medicinal Chemistry 2012.0
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains<sup>1</sup>
Journal of Medicinal Chemistry 2020.0
Structure–activity relationship studies of antiplasmodial aminomethylthiazoles
Bioorganic &amp; Medicinal Chemistry Letters 2014.0
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues
European Journal of Medicinal Chemistry 2018.0
Synthesis of five libraries of 6,5-fused heterocycles to establish the importance of the heterocyclic core for antiplasmodial activity
Bioorganic &amp; Medicinal Chemistry 2018.0
Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents
Bioorganic &amp; Medicinal Chemistry Letters 2021.0
Structure–Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors
Journal of Medicinal Chemistry 2012.0